TRAVERE THERAPEUTICS INC - NOTE 2.500% 9/1

Q4 2020 13F Portfolio Holders as of 12/31/2020

Type / Class
Debt / NOTE 2.500% 9/1
Number of holders
29
Total Principal
229M
Shares change
+1.28M
Total reported value, excl. options
$233M
Value change
+$4.19M
Put/Call ratio
0
Number of buys
14
Number of sells
-7
Price
$1.01
Investor Option Weight % Change % Value $ * Price $ Principal Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.